Last Price
51.30
Today's Change
-2.05 (3.84%)
Day's Change
51.18 - 53.53
Trading Volume
447,344
Exchange: NASDAQ Global Select NASDAQ Global Select
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Andrew J. Hykes Mr. Andrew J. Hykes
Full Time Employees: 1,300 1,300
IPO Date: 2020-05-22 2020-05-22
CIK: 0001531048 0001531048
ISIN: US45332Y1091 US45332Y1091
CUSIP: 45332Y109 45332Y109
Beta: 0.96 0.96
Last Dividend: 0.00 0.00
Dcf Diff: 90.37 90.37
Dcf: -37.02 -37.02
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.